On July 18, 2019 Flex Pharma, Inc. (Nasdaq: FLKS) reported that its Board of Directors declared a special dividend on the Company’s common stock of one right per share of outstanding common stock (Press release, Flex Pharma, JUL 18, 2019, View Source [SID1234537604]). The rights will be paid on July 19, 2019 to shareholders of record as of close of business on July 18, 2019.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Flex Pharma has not listed, and does not intend to list, the rights for trading on any exchange. The terms of the rights are described in Flex Pharma’s definitive proxy statement / prospectus / information statement dated April 29, 2019 (the "Proxy Statement"), as supplemented by the Supplement dated June 27, 2019 (the "Supplement"), both of which Flex Pharma filed with the Securities and Exchange Commission.